NIH-funded research NIH-funded research

HBV cure clues in people with and without HIV

Official title: Immune response dynamics and hepatitis B cure in persons with and without HIV infection

Funded at Johns Hopkins University · NIH-11600326 · Data updated 2026-11-12

This project studies how HBV-specific B and T cell responses relate to curing hepatitis B in people with and without HIV.

More HIV Infection research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startSeptember 17, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$4,684
NIH project number3U19AI188551-02S4
Project IDNIH-11600326 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21+ years) with HBV infection, with or without HIV, starting nucleos(t)ide analogue therapy, across diverse HBV genotypes.

Less likely to help

People not starting HBV treatment or without HBV infection would not benefit from this study.

What this research studies

Researchers will analyze longitudinal blood samples from a diverse, multi-country group starting HBV treatment to see how HBV-specific immune cells behave in people with HIV compared to those without. They will examine HBV B cells and T cells across major HBV genotypes from Uganda, Brazil, India, Senegal, and the United States to understand how genetic differences affect immune responses. The study aims to link the strength and variety of antibody responses to achieving HBV cure during nucleos(t)ide analogue therapy. Findings could reveal why some people clear HBV and how HIV co-infection changes this process. The work is conducted at Johns Hopkins University with international collaborators over several years.

Why it matters

Potential benefit: If successful, the study could inform personalized strategies to achieve HBV cure, especially in people living with HIV.

How similar studies have gone: Previous research shows immune responses are linked to HBV outcomes, but this study will expand understanding across genotypes and HIV status.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Thio, Chloe L — Johns Hopkins University
  • Study coordinator: Thio, Chloe L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.